Oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis.
A new study published in The Lancet. Respiratory Medicine was based on the hypothesis that oral amoxicillin-clavulanate and azithromycin would each be superior to placebo in achieving symptom resolution of non-severe exacerbations in children, when administered for 14 days.This was a multicenter, three-arm, parallel, double-dummy, double-blinded, randomized placebo-controlled trial conducted at four pediatriccenters in Australia and New Zealand. The study recruited children aged 1-18 years, with CT-confi
Read the full story.
Create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies